3B BlackBio Dx Limited Confirms Non-Applicability of SEBI Large Corporate Disclosure Requirements
3B BlackBio Dx Limited has formally submitted an updated declaration to BSE Limited confirming it does not qualify as a Large Corporate under SEBI regulatory framework. The declaration, submitted on April 15, 2026, with reference number P-66/2026-27/5, was digitally signed by Company Secretary Navneet Kaur and CFO Nikhil Kuber Dubey, exempting the company from specific disclosure requirements under SEBI circular dated October 19, 2023.

*this image is generated using AI for illustrative purposes only.
3b blackbio dx Limited has formally declared to BSE Limited that it does not qualify as a Large Corporate under the Securities and Exchange Board of India (SEBI) regulatory framework, thereby exempting itself from specific disclosure requirements.
Updated Regulatory Compliance Declaration
The company submitted its latest declaration on April 15, 2026, addressing the non-applicability of disclosure requirements outlined in SEBI circular SEBI/HO/DDHS/DDHSRACPOD1/P/CIR/2023/172 dated October 19, 2023. The formal communication was directed to the Department of Corporate Relations at BSE Limited.
| Parameter: | Details |
|---|---|
| Reference Number: | P-66/2026-27/5 |
| Submission Date: | April 15, 2026 |
| SEBI Circular: | SEBI/HO/DDHS/DDHSRACPOD1/P/CIR/2023/172 |
| Circular Date: | October 19, 2023 |
| Company Status: | Formerly Kilpest India Limited |
Corporate Authorization
The declaration was duly authorized and digitally signed by key company officials. Company Secretary Navneet Kaur (ACS No. 29130) and Chief Financial Officer Nikhil Kuber Dubey (DIN: 00538049) both provided their digital signatures on April 15, 2026, at 16:14:22 and 16:15:03 respectively.
SEBI Large Corporate Framework
The SEBI circular dated October 19, 2023, establishes specific criteria for categorizing companies as Large Corporates, which triggers additional disclosure obligations. By confirming its non-applicability under these criteria, 3B BlackBio Dx Limited has clarified its regulatory status and compliance obligations to the stock exchange.
The company's formal submission serves as an official record with BSE Limited, ensuring transparency regarding its regulatory classification and associated disclosure requirements under current SEBI guidelines.
Historical Stock Returns for 3B BlackBio DX
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.51% | +9.45% | +6.56% | -4.08% | -25.85% | +304.37% |
What growth trajectory would trigger 3B BlackBio Dx Limited to qualify as a Large Corporate under SEBI's framework in the future?
How might this regulatory exemption impact the company's ability to attract institutional investors who prefer enhanced disclosure requirements?
Will 3B BlackBio Dx Limited voluntarily adopt any of the Large Corporate disclosure practices to improve market transparency?


































